Nearly half of seniors quit GLP-1 weight-loss drugs within a year. Experts reveal why older Americans abandon medications ...

Low-income Californians who use Wegovy and similar weight loss drugs will lose their coverage in January. California and ...

SaveHealth reports on managing type 2 diabetes through medications, lifestyle changes, and support, highlighting various ...

New research finds statins benefit adults with type 2 diabetes across all heart-risk levels, reducing deaths and serious ...

Drugs like Ozempic, Wegovy and Zepbound have transformed how we treat obesity, but more effective treatments could be down ...

Diabetes drugs may be doing more than managing blood sugar, they could also shape cancer biology in unexpected ways.

Medicare enrollees could save roughly half of what they usually pay for certain drugs next year, according to a study from ...

In some studies, half of patients stopped taking GLP-1s within a year despite the benefits, citing the expense and side ...

Tenofovir alafenamide (Vemlidy) for the initial treatment of chronic hepatitis B may confer modestly higher rates of complete ...

The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk's weight-loss drug Wegovy, ...

Medications like Ozempic mimic a naturally occurring hormone called glucagon-like peptide-1, or GLP-1, which helps regulate ...

The study also found that women with a history of GLP-1 use had a 30% higher risk of developing gestational diabetes, a ...